The minister of finance, Sri Mulyani Indrawati, announced that Indonesian government prepared fiscal stimulus for COVID-19 vaccine importers - Photo by President Office

JAKARTA (TheInsiderStories) – The minister of finance, Sri Mulyani Indrawati, announced that Indonesian government prepared fiscal stimulus for COVID-19 vaccine imports. The policy regulated in Presidential Regulation Number 99 of 2020 and the Minister of Finance Decree Number 188 of 2020.

The decree regulated the provision of customs, excise facilities, and taxation on the imported vaccines to handle the pandemic. At the arrival of the first Sinovac vaccines to Indonesia, her ministry has facilitated the exemption of import duty, free value added tax, and luxury goods tax, and exemption from collection of income tax article 22.

“We provide services, starting from the mechanism for procurement and requirements for fiscal facilities, as well as for rush handling and from the start of notification of import of goods to the release of goods, which has been carried out for a maximum of three days,” she said on Monday (07/12).

With the presence of 1.2 million vaccines imported by the state-owned pharmacy firm, PT Bio Farma, the ministry estimated that the customs value of the import about Rp50.90 billion (US$3.67 million). The exemption from import duty is Rp14.56 billion and taxes for imports of Rp36.39 billion, she adds.

Indrawati conveyed that the directorate general of customs and excise, to provides all support for the fiscal facilities. In the service process, the ministry’ unit will collaborates with the ministry of health, the Food and Drug Supervisory Agency, and the Indonesia National Single Window.

Talking on the distribution planned, minister of health, Terawan Agus Putranto added, the government now in the process to creates a road map. The government has also set priority groups for COVID-19 vaccine recipients. He asserted, “The first ones who will be targeted are health workers, health worker assistants, and support personnel who work in Health Service Facilities.”

Now, said Hadiputranto, his office is waiting for an emergency use authorization from the Food and Drug Administration before holding a mass vaccination for the COVID-19 vaccine. As reported, Indonesia officially received 1.2 million doses of prospective vaccine candidates from Sinovac.

The COVID-19 vaccine made by Sinovac, has arrived at Soekarno – Hatta International Airport, Tangerang, Banten, on Sunday night and was immediately taken to the Bio Farma head office in Bandung, West Java. Then the vaccine sample will be taken for quality testing by a team from the food and drug tester agency and the drug-maker office.

FiUS$1: Rp14,100

Written by Editorial Staff, Email: